Terence Flynn
Stock Analyst at Morgan Stanley
(4.56)
# 939
Out of 4,352 analysts
1009
Total ratings
56.7%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Terence Flynn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHVN Biohaven | Maintained: Buy | $18 | $10.24 | +75.78% | 18 | May 28, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Sell | $40 | $56.91 | -29.71% | 48 | May 26, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $126 → $90 | $93.44 | -4.16% | 84 | May 18, 2026 | |
| ALMS Alumis | Maintained: Buy | $38 → $39 | $21.40 | +82.24% | 9 | May 15, 2026 | |
| BIIB Biogen | Maintained: Hold | $206 | $196.39 | +4.89% | 58 | May 14, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Hold | $15 | $13.68 | +9.65% | 18 | May 13, 2026 | |
| LEGN Legend Biotech | Maintained: Buy | $49 → $48 | $28.26 | +69.85% | 7 | May 13, 2026 | |
| PRME Prime Medicine | Maintained: Hold | n/a | $3.40 | - | 10 | May 13, 2026 | |
| RCUS Arcus Biosciences | Maintained: Hold | $20 → $22 | $24.48 | -10.13% | 15 | May 11, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $175 → $168 | $136.22 | +23.33% | 57 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $519 → $516 | $562.09 | -8.20% | 32 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $64 | $54.48 | +17.47% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $26.14 | +7.12% | 57 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $612 → $616 | $447.97 | +37.51% | 52 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $326 → $332 | $336.48 | -1.33% | 52 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,327 → $1,344 | $1,126.80 | +19.28% | 77 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $109 → $112 | $119.89 | -6.58% | 52 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $30 → $33 | $47.57 | -30.63% | 32 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $796 → $788 | $621.52 | +26.79% | 57 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $270 → $278 | $218.63 | +27.16% | 51 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $267 → $283 | $230.80 | +22.62% | 54 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $13.35 | -32.58% | 28 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 | $8.84 | +24.43% | 24 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $126 | $40.17 | +213.67% | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $32 → $33 | $56.38 | -41.47% | 13 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $17.67 | +103.74% | 16 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.66 | - | 11 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.43 | n/a | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $16 | $39.94 | n/a | 13 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $12 | $3.71 | n/a | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €90.43 | $129.95 | n/a | 1 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $41.56 | $7.48 | n/a | 1 | Dec 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $16 | $90.86 | n/a | 2 | Mar 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $163 → $155 | $305.06 | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $50.84 | n/a | 1 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $31 | $7.01 | n/a | 4 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $30.42 | n/a | 4 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $38 | $11.26 | n/a | 1 | Nov 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $36 | $7.58 | n/a | 1 | Jul 21, 2015 |
Biohaven
May 28, 2026
Maintained: Buy
Price Target: $18
Current: $10.24
Upside: +75.78%
Bristol-Myers Squibb Company
May 26, 2026
Maintained: Sell
Price Target: $40
Current: $56.91
Upside: -29.71%
BioNTech SE
May 18, 2026
Maintained: Buy
Price Target: $126 → $90
Current: $93.44
Upside: -4.16%
Alumis
May 15, 2026
Maintained: Buy
Price Target: $38 → $39
Current: $21.40
Upside: +82.24%
Biogen
May 14, 2026
Maintained: Hold
Price Target: $206
Current: $196.39
Upside: +4.89%
Intellia Therapeutics
May 13, 2026
Maintained: Hold
Price Target: $15
Current: $13.68
Upside: +9.65%
Legend Biotech
May 13, 2026
Maintained: Buy
Price Target: $49 → $48
Current: $28.26
Upside: +69.85%
Prime Medicine
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $3.40
Upside: -
Arcus Biosciences
May 11, 2026
Maintained: Hold
Price Target: $20 → $22
Current: $24.48
Upside: -10.13%
Gilead Sciences
May 8, 2026
Maintained: Buy
Price Target: $175 → $168
Current: $136.22
Upside: +23.33%
May 7, 2026
Maintained: Hold
Price Target: $519 → $516
Current: $562.09
Upside: -8.20%
May 7, 2026
Maintained: Buy
Price Target: $63 → $64
Current: $54.48
Upside: +17.47%
May 6, 2026
Maintained: Hold
Price Target: $28
Current: $26.14
Upside: +7.12%
May 5, 2026
Rated: Buy
Price Target: $612 → $616
Current: $447.97
Upside: +37.51%
May 1, 2026
Rated: Hold
Price Target: $326 → $332
Current: $336.48
Upside: -1.33%
May 1, 2026
Maintained: Buy
Price Target: $1,327 → $1,344
Current: $1,126.80
Upside: +19.28%
May 1, 2026
Maintained: Hold
Price Target: $109 → $112
Current: $119.89
Upside: -6.58%
May 1, 2026
Rated: Hold
Price Target: $30 → $33
Current: $47.57
Upside: -30.63%
Apr 30, 2026
Maintained: Hold
Price Target: $796 → $788
Current: $621.52
Upside: +26.79%
Apr 30, 2026
Maintained: Buy
Price Target: $270 → $278
Current: $218.63
Upside: +27.16%
Apr 15, 2026
Rated: Buy
Price Target: $267 → $283
Current: $230.80
Upside: +22.62%
Apr 10, 2026
Maintained: Hold
Price Target: $9
Current: $13.35
Upside: -32.58%
Mar 18, 2026
Maintained: Hold
Price Target: $11
Current: $8.84
Upside: +24.43%
Feb 27, 2026
Maintained: Buy
Price Target: $125 → $126
Current: $40.17
Upside: +213.67%
Feb 17, 2026
Maintained: Sell
Price Target: $32 → $33
Current: $56.38
Upside: -41.47%
Jan 30, 2026
Maintained: Buy
Price Target: $36
Current: $17.67
Upside: +103.74%
Sep 21, 2025
Maintained: Hold
Price Target: n/a
Current: $3.66
Upside: -
Dec 13, 2024
Maintained: Hold
Price Target: n/a
Current: $3.43
Upside: n/a
Jun 1, 2021
Maintained: Sell
Price Target: $16
Current: $39.94
Upside: n/a
Aug 10, 2020
Maintained: Hold
Price Target: $21 → $12
Current: $3.71
Upside: n/a
Aug 3, 2020
Upgraded: Buy
Price Target: €90.43
Current: $129.95
Upside: n/a
Dec 2, 2019
Initiated Coverage: Hold
Price Target: $41.56
Current: $7.48
Upside: n/a
Mar 25, 2019
Downgraded: Hold
Price Target: $18 → $16
Current: $90.86
Upside: n/a
Aug 13, 2018
Maintained: Buy
Price Target: $163 → $155
Current: $305.06
Upside: n/a
Jun 18, 2018
Initiated Coverage: Hold
Price Target: $22
Current: $50.84
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $32 → $31
Current: $7.01
Upside: n/a
Jun 13, 2016
Maintained: Hold
Price Target: $46
Current: $30.42
Upside: n/a
Nov 18, 2015
Rated: Hold
Price Target: $38
Current: $11.26
Upside: n/a
Jul 21, 2015
Initiated Coverage: Hold
Price Target: $36
Current: $7.58
Upside: n/a